← All stocks

Anika Therapeutics, Inc.

ANIK Net buying
CIK 0000898437 #3636 in the set updated 18 Sep 2026
Bought (12 mo)
$264.26K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$264.26K
+$264.26K against sales at will

By person

13 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Griffin Stephen D.
President and CEO
$149.88K (1)
+$149.88K
45,973
0.3435%
$933.94K
+1,865%
HENNEMAN JOHN B III
Director
$73.32K (1)
+$73.32K
65,273
0.4877%
$1.33M
+82.8%
Fischetti Gary P
Director
$41.06K (2)
+$41.06K
54,015
0.4036%
$1.10M
+96.8%
Blanchard Cheryl R
Director
258,788
1.93%
$5.26M
+69.3%
Colleran David
EVP, General Counsel, Corp Sec
67,570
0.5049%
$1.37M
+89.1%
Richard Stephen
Director
58,273
0.4354%
$1.18M
+72.9%
CONLEY SHERYL L
Director
52,970
0.3958%
$1.08M
+86.5%
Larsen Glenn R.
Director
50,258
0.3755%
$1.02M
+39.2%
VOGT SUSAN L N
Director
50,213
0.3752%
$1.02M
+39.3%
Capper Joseph H
Director
30,805
0.2302%
$625.80K
+393.7%
McLeod Ian
SVP, CAO & Treasurer
24,107
0.1801%
$489.73K
+40.3%
Nunes Anne
SVP, Chief Operations Officer
20,654
0.1543%
$419.59K
+69.6%
Jellison William R
Director
20,403
0.1525%
$414.49K
+227.0%
Insider
Date
Role
Action
Shares
Price
Amount
Fischetti Gary P
4 Aug 2026
Director
Buy
1,000
$20.32
$20.32K
Fischetti Gary P
3 Aug 2026
Director
Buy
1,000
$20.75
$20.75K
HENNEMAN JOHN B III
1 May 2026
Director
Buy
5,000
$14.66
$73.32K
Griffin Stephen D.
30 Apr 2026
President and CEO
Buy
12,200
$12.29
$149.88K

What was left out

Form 4 filings counted 18
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 267,308
History held since 4 Nov 2016